GEJ Signet Ring Cell with skip lesion to mid Esophagus post neoadjuvant
- Abdullah Sindy
, - Abdulnasir Batouk,
- Fahad AlAmoudi,
- Ataa AlBaroudi
Abstract
Signet ring cells consider one of the rare diagnosis that can be managed
among the oncological diseases.Confined on poor prognosis and
advancement of their stage.Not seems to be affected properly with the
chemotherapy. And still the surgical option is the best in operable case
to decrease the burden
